GlassScriptPhysician profile
Patricia Whitcombe
NPI 1275543290
$677.06
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $85.07 · 2021: $38.15 · 2022: $185 · 2023: $106 · 2024: $65.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $88.35 | 2020-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $77.58 | 2022 | |
| Therapeuticsmd, INC. | $71.98 | 2019-2020 | |
| Pfizer INC. | $54.81 | 2022 | |
| Vertical Pharmaceuticals, LLC | $53.76 | 2019-2020 | |
| Daiichi Sankyo INC. | $52.08 | 2019-2023 | Injectafer |
| Astellas Pharma US INC | $48.59 | 2019-2024 | Veozah |
| Amag Pharmaceuticals, INC. | $45.03 | 2019 | |
| Myovant Sciences INC. | $36.19 | 2022 | |
| Exeltis, USA INC. | $33.28 | 2023 | Slynd |
| Exact Sciences Corporation | $30.16 | 2024 | Cologuard Collection Kit |
| Medtronic Vascular, INC. | $21.25 | 2019 | |
| Organon LLC | $18.38 | 2024 | |
| Amgen INC. | $17.12 | 2023 | Evenity, Prolia |
| Lupin INC. | $16.90 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Whitcombe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.